Product/Service

Optim®2 System

Source: Pall Life Sciences - BioPharmaceuticals

Optim2

The Optim 2 from Avacta Analytical is a compact and robust, high throughput microvolume protein analysis and characterization instrument, that combines data from multiple analytical methods to generate a wide range of stability-indicating parameters.

Request Information

The Optim 2 from Avacta Analytical is a compact and robust, high throughput microvolume protein analysis and characterization instrument, that combines data from multiple analytical methods to generate a wide range of stability-indicating parameters.

The Optim 2 provides considerable benefits, allowing you to take advantage of the following stability indicators earlier in your decision-making process in order to build a comprehensive picture of, and provide greater insight into, the stability of a protein or formulation:

  • thermal unfolding midpoint (Tm);
  • onset temperature of unfolding;
  • rate of unfolding;
  • aggregation onset and rates of aggregation;
  • mean molecular mass and relative degree of aggregation;
  • relative degree of tertiary structure.

Taking the total investment for all candidates, both successes and failures, into account, the cost of bringing a new drug to market varies from between 3 and 12 billion US dollars. A solution that can potentially reduce this risk of failure has significant value to the industry and biopharmaceutical developers.

Need More Information? Just Ask.

Click the button below to directly contact the supplier. Use it to:

  • Ask a question.
  • Request more detailed information or literature.
  • Discuss your current project/application.
  • Request a quote.
  • Locate a distributor in your area.
  • Schedule a demo.
Request Information

Pall Life Sciences - BioPharmaceuticals